Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy

被引：0
|
作者：
Nakashima, J. Y. [1 ]
Khatri, V. [1 ]
Cruz-Chamorro, R. J. [1 ]
Zhou, J. [2 ]
Patra, P. [2 ]
Gonzalez, R. [3 ]
De Avila, G. [3 ]
Locke, F. L. [3 ]
Liu, H. D. [3 ]
Nishihori, T. [3 ]
Puglianini, O. C. [3 ]
Alsina, M. [3 ]
Garjales-Cruz, A. [4 ]
Baz, R. [4 ]
Shah, B. D. [4 ]
Shain, K. [4 ]
Jain, M. D. [3 ]
Hansen, D. [3 ]
Freeman, C. [3 ]
Figura, N. B. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Univ S Florida, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1121
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [41] Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma
    Meera Mohan
    Aniko Szabo
    Anannya Patwari
    Jean Esselmann
    Tanvi Patel
    Ramya Bachu
    Lisa E. Rein
    Abhishek Janardan
    Vineel Bhatlapenumarthi
    Evanka Annyapu
    Catherine Skoog
    Areyl Goff
    Samer Al Hadidi
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Maurizio Zangari
    Nirav Shah
    Frits van Rhee
    Binod Dhakal
    Mehdi Hamadani
    Anita D’Souza
    Carolina Schinke
    Bone Marrow Transplantation, 2024, 59 : 647 - 652
  • [42] Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma
    Mohan, Meera
    Szabo, Aniko
    Patwari, Anannya
    Esselmann, Jean
    Patel, Tanvi
    Bachu, Ramya
    Rein, Lisa E.
    Janardan, Abhishek
    Bhatlapenumarthi, Vineel
    Annyapu, Evanka
    Skoog, Catherine
    Goff, Areyl
    Hadidi, Samer Al
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    Shah, Nirav
    van Rhee, Frits
    Dhakal, Binod
    Hamadani, Mehdi
    D'Souza, Anita
    Schinke, Carolina
    BONE MARROW TRANSPLANTATION, 2024, 59 (05) : 647 - 652
  • [43] The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma
    Feinberg, Daniel
    Paul, Barry
    Kang, Yubin
    CELLULAR IMMUNOLOGY, 2019, 345
  • [44] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
    Zhang, Xiaohui
    Ouyang, Chenxi
    Sun, Guofeng
    Liu, Hongfeng
    Qi, Junyuan
    Suo, Xiaohui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
  • [45] Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy
    Qi, Yuekun
    Li, Hujun
    Qi, Kunming
    Zhu, Feng
    Cheng, Hai
    Chen, Wei
    Yan, Zhiling
    Li, Depeng
    Sang, Wei
    Fei, Xiaoming
    Gu, Weiying
    Miao, Yuqing
    Huang, Hongming
    Wang, Ying
    Qiu, Tingting
    Qiao, Jianlin
    Pan, Bin
    Shi, Ming
    Wang, Gang
    Li, Zhenyu
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2286 - 2295
  • [46] Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials
    Que, Yimei
    Xu, Menglei
    Xu, Yanjie
    Almeida, Varlene Daniela Fernandes
    Zhu, Li
    Wang, Zhiqiong
    Wang, Ying
    Liu, Xian
    Jiang, Lijun
    Wang, Di
    Li, Chunrui
    Zhou, Jianfeng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] B- Cell Maturation Antigen (BCMA) Re-Emergence and Relapse Patterns Post-BCMA-Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Multiple Myeloma
    Wesson, William
    Cui, Wei
    Mushtaq, Muhammad
    Bansal, Rajat
    Singh, Anurag K.
    Hoffmann, Marc
    Tun, Aung M.
    Balusu, Ramesh
    Abdelhakim, Haitham
    Abhyankar, Sunil H.
    McGuirk, Joseph P.
    Shune, Leyla O.
    Abdallah, Al-Ola
    Ahmed, Nausheen
    BLOOD, 2022, 140 : 12781 - 12783
  • [48] Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
    Mohammed, Turab
    Peres, Lauren
    Colinleitzinger, Christelle
    Puglianini, Omar Castaneda
    Oswald, Laura
    De Avila, Gabe
    Grajales-Cruz, Ariel
    Blue, Brandon
    Ochoa-Bayona, Jose
    Khimani, Farhad
    Faramand, Rawan
    Elmariah, Hany
    Lazaryan, Aleksandr
    Jain, Michael
    Liu, Hein
    Nishihori, Taiga
    Shain, Ken
    Baz, Rachid
    Alsina, Melissa
    Locke, Frederick
    Freeman, Ciara
    Hansen, Doris
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S473 - S474
  • [49] Tumor and immune determinants of response to anti-BCMA CAR T-cell therapy in multiple myeloma using cell-free DNA
    Carleton, Mia
    Hosoya, Hitomi
    Tanaka, Kailee L.
    Sworder, Brian
    Hovanky, Vanna
    Sahaf, Bita
    Frank, Matthew J.
    Duran, George E.
    Zhang, Tian Y.
    Arai, Sally
    Iberri, David
    Liedtke, Michaela
    Miklos, David B.
    Khodadoust, Michael S.
    Sidana, Surbhi
    Kurtz, David M.
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Anti-BCMA CAR T-Cell Therapy in Patients with Refractory Myasthenia Gravis
    Qin, Chuan
    Tian, Dai-Shi
    Dong, Ming-Hao
    Hing, Michael
    Zhou, Luo-Qi
    Wang, Wen
    Song-Bai
    Li, Chun-Rui
    Wang, Di
    Zhang, Min
    Bu, Bi-Tao
    zu Hoerste, Gerd Meyer
    Wang, Wei
    ANNALS OF NEUROLOGY, 2024, 96 : S98 - S99
12345